Copper-dependent toxicity in SH-SY5Y neuroblastoma cells involves mitochondrial damage

Peňa, 1999, A delicate balance: homeostatic control of copper uptake and distribution, J. Nutr., 129, 1251, 10.1093/jn/129.7.1251 Nalbandyan, 1983, Copper in brain, Neurochem. Res., 8, 1211, 10.1007/BF00963993 Halliwell, 1990, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol., 186, 1, 10.1016/0076-6879(90)86093-B Cadenas, 2002, Mitochondrial free radical generation, oxidative stress and aging, Free Radic. Biol. Med., 29, 222, 10.1016/S0891-5849(00)00317-8 Jeon, 2000, Thiol reactive metal compounds inhibit NFkB by blocking IkB kinase, J. Immunol., 164, 5981, 10.4049/jimmunol.164.11.5981 Cecconi, 2002, Oxidative modification of aldose reductase by copper ion: definition of the metal–protein interaction mechanism, J. Biol. Chem., 277, 42017, 10.1074/jbc.M206945200 Brewer, 2000, Recognition, diagnosis and management of Wilson’s disease, Exp. Biol. Med., 223, 39, 10.1046/j.1525-1373.2000.22305.x Lutzenko, 1998, Localization of the Wilson’s disease protein product to the mitochondria, Proc. Natl. Acad. Sci. USA, 95, 6004, 10.1073/pnas.95.11.6004 Stenlieb, 1968, Mitochondrial and fatty acid changes in hepatocytes of patients with Wilson’s disease, Gastroenterology, 55, 354, 10.1016/S0016-5085(19)34045-4 Sokol, 1994, Oxidant injury to hepatic mitochondria in patients with Wilson’s disease and Bedlington terriers with copper toxicosis, Gastroenterology, 107, 1788, 10.1016/0016-5085(94)90822-2 Gu, 2000, Oxidative phosphorylation defects in liver of patients with Wilson’s disease, Lancet, 356, 469, 10.1016/S0140-6736(00)02556-3 Sheline, 2002, Cofactors of mitochondrial enzymes attenuate copper induced death in vitro and in vivo, Ann. Neurol., 52, 195, 10.1002/ana.10276 Sheline, 2004, Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo, Ann. Neurol., 55, 645, 10.1002/ana.20047 Barnham, 2004, Neurodegenerative diseases and oxidative stress, Nat. Rev. Drug Discov., 3, 205, 10.1038/nrd1330 Rotilio, 2002, Disturbances of copper homeostasis and brain function, 277 Bush, 2002, Metal complexing agents as therapies for Alzheimer’s disease, Neurobiol. Aging, 23, 1031, 10.1016/S0197-4580(02)00120-3 Nijtmans, 2002, Blue native electrophoresis to study mitochondrial and other protein complexes, Methods, 26, 327, 10.1016/S1046-2023(02)00038-5 Lombardo, 2003, Prolonged copper depletion induces expression of antioxidants and triggers apoptosis in SH-SY5Y neuroblastoma cells, Cell. Mol. Life Sci., 60, 1733, 10.1007/s00018-003-3153-1 Royall, 1993, Evaluation of 2′,7′-dichlorofluorescein and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells, Arch. Biochem. Biophys., 302, 348, 10.1006/abbi.1993.1222 Lowry, 1951, Protein measurement with the Folin-phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Narayanan, 2001, Tumor suppressor protein p53 mRNA and subcellular localization are altered by changes in cellular copper in human HepG2 cells, J. Nutr., 131, 1427, 10.1093/jn/131.5.1427 Lee, 2001, J. Neurochem., 78, 209, 10.1046/j.1471-4159.2001.00417.x Freedman, 1986, Resistance to copper toxicity of cultured hepatoma cells, J. Biol. Chem., 261, 11840, 10.1016/S0021-9258(18)67319-3 Beretta, 2003, Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetyl cysteine, Neurobiol. Dis., 13, 213, 10.1016/S0969-9961(03)00043-3 Seth, 2004, In vitro assessment of copper-induced toxicity in human hepatoma cell line HepG2, Toxicology, 18, 501 Nishimura, 2004, Cellular prion protein regulates intracellular hydrogen peroxide level and prevents copper-induced apoptosis, Biochem. Biophys. Res. Commun., 323, 218, 10.1016/j.bbrc.2004.08.087 Cobine, 2004, Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix, J. Biol. Chem., 279, 14447, 10.1074/jbc.M312693200 Buettner, 1996, Catalytic metals ascorbate and free radicals: combinations to avoid, Radiat. Res., 145, 532, 10.2307/3579271 Grünewald, 1993, Ascorbic acid in the brain, Brain Res. Brain Res. Rev., 18123 Schapira, 1998, Human complex I defects in neurodegenerative diseases, Biochim. Biophys. Acta, 1364, 261, 10.1016/S0005-2728(98)00032-2 Beer, 2004, Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins, J. Biol. Chem., 279, 47939, 10.1074/jbc.M408011200 Comelli, 1998, Severe energy impairment consequent to inactivation of mitochondrial ATP synthase as an early event in cell death: a mechanism for the selective sensitivity to H2O2 of differentiating erythroleukemia cells, Free Radic. Biol. Med., 24, 924, 10.1016/S0891-5849(97)00373-0 Lombardo, 2003, Copper imbalance, oxidative stress and mitochondrial damage in neuroblastoma cells, 115 Mattie, 2004, Copper inducible transcription: regulation by metal- and oxidative stress-responsive pathways, Am. J. Cell Physiol., 286, C293, 10.1152/ajpcell.00293.2003 Rossi, 2004, Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance, Neurochem. Res., 29, 493, 10.1023/B:NERE.0000014820.99232.8a Pasinelli, 2004, Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria, Neuron, 43, 19, 10.1016/j.neuron.2004.06.021